Navigation Links
MannKind Corporation Reports Third Quarter Financial Results
Date:11/5/2008

and efficacy in the treatment of diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press release as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to email alerts that are sent automatically when MannKind issues press releases, files its reports with the SEC or posts certain other information to the website.

Forward-Looking Statements

This press release contains forward-looking statements, including statements related to MannKind's expected R&D and G&A expenses, clinical trials, product candidates, regulatory submissions, manufacturing facility and partnership opportunities that involve risks and uncertainties. Words such as "believes", "anticipates", "plans", "expects", "intend", "will", "goal", "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the Company's current expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the progress, timing and results of clinical trials, difficulties or delays in seeking or obtaining regulatory approval, the manufacture of AFRESA, competition from other pharmaceutical or biotechnology companies, MannKind's ability to enter into any collaborations or strategic partnerships, intellectual property matters, stock price volatility and other risks detailed in MannKind's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2007 and periodic reports on Form 10-Q and Form 8-K. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Al
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. MannKind Corporation to Host Webcast Analyst Day September 16, 2008
2. The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
3. MannKind to Present at the Cowen and Company Healthcare Conference
4. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
5. MannKind Corporation Reports Third Quarter Financial Results
6. MannKind to Present at Upcoming Conferences
7. MannKind Announces New $350 Million Credit Facility
8. Providence Service Corporation Releases Third Quarter Results
9. United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results
10. Psychemedics Corporation Announces Third Quarter Results
11. Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... The partnership will leverage ... technical support services to promote LodonalTM in Nigeria. The distribution will become effective, ... and safety of the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis ...
(Date:9/2/2015)... ... 03, 2015 , ... Leah Binder, MA, MGA, president and ... in healthcare, will offer the keynote address at the upcoming meeting of the ... Palm Harbor, Florida, at the Innisbrook Resort and Golf Club. For an agenda ...
(Date:9/2/2015)... ... September 03, 2015 , ... Each year, ... America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health care professionals, and others ... that process led the magazine to tap the National League for Nursing’s outspoken ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... (WFS), cosponsored by the Military Officers Association of America (MOAA) and Wounded ... Nation's Military: Caring For Our Own,” expert panelists will lead interactive discussions ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Based in ... their fleet of truly superb luxury vehicles based on which of the latest and ... announce the latest step forward in pursuit of this goal: a 2015 Rolls ...
Breaking Medicine News(10 mins):Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
... , , Patient-Based Record ... , MADISON, N.J., July 20 MedPlus, the ... DGX ), today announced that NYCLIX is now sharing ... New York City using the company,s Centergy(TM) suite of ...
... , SEOUL, South Korea, July 20 ... to announce that its wholly owned subsidiary, VASKA, a ... institutional, and consumer markets, has successfully turned the first major commercial ... Royal Laundry of South San Francisco is the largest ...
... , , ... campaign in support of bipartisan health care reform. , ... Plans (AHIP), "Illness", calls for fixing health care to make sure all Americans ... , "Illness doesn,t care where you live. . .or if ...
... , , , ... Oldsmar, Fla., July 20 /PRNewswire-FirstCall/ -- Women today have a number ... of their families. Banking stem cells found in menstrual blood is one way ... injuries. Menstrual blood has been shown to contain self-renewing stem cells that may ...
... Calif., July 20 SynergEyes, Inc., the high Dk ... lens design for keratoconus patients. ClearKone(TM) is a revolutionary ... of the hybrid platform, providing superior visual acuity, centration, ... to vault the predominant irregularities of the keratoconic cornea, ...
... , , BRIDGEWATER, ... pooled results from two Phase 3 studies (DUET-1 and ... non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI) ... copies/mL) while taking INTELENCE(TM) (etravirine) tablets plus background regimen ...
Cached Medicine News:Health News:Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care 2Health News:Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care 3Health News:Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care 4Health News:HepaHope Korea Subsidiary VASKA Introduces Green Chemicals to U.S. Commercial Laundry Industry 2Health News:Health Plans Return to Airwaves in Support of Bipartisan Reform 2Health News:C'elle(SM) Featured on ABC Action News in Tampa Bay 2Health News:C'elle(SM) Featured on ABC Action News in Tampa Bay 3Health News:C'elle(SM) Featured on ABC Action News in Tampa Bay 4Health News:C'elle(SM) Featured on ABC Action News in Tampa Bay 5Health News:SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients 2Health News:SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients 3Health News:96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 2Health News:96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 3Health News:96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 4Health News:96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 5Health News:96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy 6
(Date:9/2/2015)... Sept. 2, 2015  Research and Markets ( ... "An Introduction to the Medical Devices Directive ... to their offering. This seminar ... device legislation. It will explain the Directives and ... Bodies, how to choose one and outline what ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. Advances in understanding ... opened new avenues and possibilities for improved drug ... systems, enzymes, and receptors that control the penetration ...
(Date:9/2/2015)... 2015  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, announced today that the first ... 1/2a clinical trial of AGT-181 in patients with ... AGT-181 is an investigational enzyme replacement therapy ... most severe form of MPS I, Hurler syndrome, ...
Breaking Medicine Technology:Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... -- MAP,Pharmaceuticals, Inc. today announced that it will ... clinical program at the 49th,Annual American Headache Society ... The poster presentation, which was,accepted as a late-breaker, ... of Inhaled Dihydroergotamine Mesylate,via a Novel Inhaler (Tempo(TM) ...
... Professor Home said: , "The editorials published by ... disregarded important pieces of data that,are extremely relevant ... data that showed no evidence,of any increase in ... Philip Home , CONTACT: Professor Philip Home, (44) ...
Cached Medicine Technology:MAP Pharmaceuticals to Present MAP0004 Phase 2 Clinical Data at the,American Headache Society Meeting 2
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... a critical component of pain relief, functional ... Lumbosacral Bracing System™ offers the practitioner multiple ... of immobilization, unparalled comfort, and the ability ... even if they gain or lose weight. ...
... Aspen® Cervical Collars were designed to optimize ... better patient outcomes. The structure of the ... restriction without producing painful pressure points that ... patient compliance. For the ultimate in comfort, ...
... This comfortable pre-fabricated orthosis is designed ... distal third humeral diaphyseal fractures. The ... circumferential soft tissue compression for optimal ... range-of- motion of both shoulder and ...
Medicine Products: